Time is running out to get a discount on Xconomy’s annual Boston biotech bash, “What’s Hot in Boston Biotech.” We’re putting together a huge star-studded lineup of local biotech leaders to discuss some of the top issues, trends, and emerging technologies, set to shape life sciences in the years to come.
Join us on May 11 at Biogen in Cambridge, MA, to take a look at what Boston innovators are focusing on, what ideas are moving forward, and how companies plan to handle the shifting political and healthcare landscapes.
— Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute
— Stelios Papadopoulos, Chairman of the Board, Biogen; Co-founder & Chairman of the Board, Exelixis
— Richard Pops, Chairman & CEO, Alkermes
— Noubar Afeyan, Founder, Senior Managing Partner & CEO, Flagship Pioneering
— Katrine Bosley, CEO, Editas Medicine
— Susan Windham-Bannister, Ph.D., President and CEO, Biomedical Growth Strategies; Managing Partner, Biomedical Innovation Advisors
— Michael Gilman, CEO & Chairman, Arrakis Therapeutics
— Abbie Celniker, Partner, Third Rock Ventures
— David Schenkein, CEO, Agios Pharmaceuticals
— Ed Kaye, President, CEO & Chief Medical Office, Sarepta Therapeutics
— Tony Coles, Chairman & CEO, Yumanity Therapeutics
— Jeremy Levin, CEO, Ovid Therapeutics; former CEO, Teva Pharmaceutical Industries
Hurry and register by midnight to save with the saver rate. See you on May 11!